{"disease":{"id":"diffuse-lung-disease","name":"diffuse lung disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT05425875","title":"Comparison of Procedural Yield of Bronchoalveolar Lavage Using Three Different Techniques in Subjects Undergoing Flexible Bronchoscopy","phase":"NA","overall_status":"COMPLETED","enrollment_count":942,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false},{"nct_id":"NCT03704233","title":"The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":350,"lead_sponsor_name":"Guangzhou Institute of Respiratory Disease","has_results":false},{"nct_id":"NCT06618924","title":"Digital Modeling of Thoracic CT and Pulmonary Fibrosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02229994","title":"Development of a New Tool for Dyspnea Measurement in Chronic Respiratory Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05270668","title":"Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":154,"lead_sponsor_name":"Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","has_results":false},{"nct_id":"NCT04657484","title":"Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false},{"nct_id":"NCT02961335","title":"Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases","phase":"NA","overall_status":"TERMINATED","enrollment_count":38,"lead_sponsor_name":"University Hospital, Rouen","has_results":false},{"nct_id":"NCT02615938","title":"Hydroxychloroquine (HCQ) in Pediatric Interstitial Lung Disease (ILD)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":35,"lead_sponsor_name":"Matthias Griese","has_results":true},{"nct_id":"NCT07301697","title":"Safety and Performance Profile of Cryobiopsy in Bronchial Endoscopy","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT04392726","title":"Ultra-Low Dose Computed Tomography For Diagnosis And Follow-Up Of Patients With Diffuse Parenchymal Lung Disease (DPLD)","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT06171425","title":"Evaluation of Patients With Diffuse Parenchymal Lung Diseases Regarding Frailty","phase":"","overall_status":"UNKNOWN","enrollment_count":28,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT03630211","title":"Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":8,"lead_sponsor_name":"Paul Szabolcs","has_results":false},{"nct_id":"NCT04837131","title":"A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Michael M. Pham","has_results":true}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}